EPGAX
Price
$21.68
Change
+$0.08 (+0.37%)
Updated
Jul 25 closing price
Net Assets
12.3B
GFFFX
Price
$84.21
Change
+$0.07 (+0.08%)
Updated
Jul 28 closing price
Net Assets
328.1B
Interact to see
Advertisement

EPGAX vs GFFFX

Header iconEPGAX vs GFFFX Comparison
Open Charts EPGAX vs GFFFXBanner chart's image
Fidelity Advisor Equity Growth A
Price$21.68
Change+$0.08 (+0.37%)
VolumeN/A
Net Assets12.3B
American Funds Growth Fund of Amer F2
Price$84.21
Change+$0.07 (+0.08%)
VolumeN/A
Net Assets328.1B
EPGAX vs GFFFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EPGAX vs. GFFFX commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPGAX is a Buy and GFFFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFFFX has more cash in the bank: 328B vs. EPGAX (12.3B). GFFFX pays higher dividends than EPGAX: GFFFX (0.53) vs EPGAX (0.00). EPGAX was incepted earlier than GFFFX: EPGAX (29 years) vs GFFFX (17 years). EPGAX (0.92) is less costly to investors than GFFFX (0.40). EPGAX is a more actively managed with annual turnover of: 52.00 vs. GFFFX (25.00). EPGAX has a lower initial minimum investment than GFFFX: EPGAX (0) vs GFFFX (250). GFFFX annual gain was more profitable for investors over the last year : 18.04 vs. EPGAX (6.96). GFFFX (50.15) and EPGAX (48.29) have equivalent 5 years return.
EPGAXGFFFXEPGAX / GFFFX
Total Expense Ratio0.920.40230%
Annual Report Gross Expense Ratio0.920.40230%
Fund Existence29 years17 years-
Gain YTD9.82813.44273%
Front Load6%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets12.3B328B4%
Annual Yield % from dividends0.000.53-
Returns for 1 year6.9618.0439%
Returns for 3 years59.2959.30100%
Returns for 5 years48.2950.1596%
Returns for 10 years116.9388.28132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITOS10.170.02
+0.20%
iTeos Therapeutics
TTEK38.300.03
+0.08%
Tetra Tech Inc
RKDA4.19N/A
N/A
Arcadia Biosciences
NEO6.29-0.13
-2.02%
NeoGenomics
XOS3.34-0.17
-4.84%
Xos